Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-02

Clinical Trial Update: Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treatment of high-grade cervical intraepithelial neoplasia (CIN 2/3) has completed with results posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Cervical Intraepithelial Neoplasia, Cervical Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2024-05-02